Effects of diaphragmatic myofascial release on gastroesophageal reflux disease : a preliminary randomized controlled trial
| Autor: | Xavier Cortés, A. Barrasa-Shaw, P. Almela-Notari, J. C. Campos-González, Isabel Martínez-hurtado, Juan Francisco Lisón, Maria Dolores Arguisuelas |
|---|---|
| Přispěvatelé: | UCH. Departamento de Fisioterapia (Extinguido), Producción Científica UCH 2019, UCH. Departamento de Medicina (Extinguido), UCH. Departamento de Cirugía (Extinguido), UCH. Departamento de Medicina y Cirugía, UCH. Departamento de Enfermería y Fisioterapia |
| Rok vydání: | 2019 |
| Předmět: |
Male
0301 basic medicine medicine.medical_specialty Diaphragm Gastroesophageal reflux disease - Treatment lcsh:Medicine Diaphragmatic breathing Therapeutics Disease Gastroenterology Article law.invention 03 medical and health sciences 0302 clinical medicine Quality of life Randomized controlled trial law Surveys and Questionnaires Internal medicine Digestive organs - Diseases - Treatment Humans Medicine lcsh:Science Aparato digestivo - Enfermedades - Tratamiento Gastrointestinal diseases Massage Multidisciplinary business.industry Stomach - Diseases - Treatment lcsh:R Reflux Proton Pump Inhibitors medicine.disease Estómago - Enfermedades - Tratamiento Diaphragm (structural system) Myofascial release Treatment Outcome 030104 developmental biology Gastroesophageal Reflux Quality of Life GERD lcsh:Q Female business Enfermedad por reflujo gastroesofágico - Tratamiento 030217 neurology & neurosurgery |
| Zdroj: | CEU Repositorio Institucional Fundación Universitaria San Pablo CEU (FUSPCEU) Scientific Reports SCIENTIFIC REPORTS r-FISABIO. Repositorio Institucional de Producción Científica instname r-FISABIO: Repositorio Institucional de Producción Científica Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) Scientific Reports, Vol 9, Iss 1, Pp 1-7 (2019) |
| ISSN: | 2045-2322 |
| DOI: | 10.1038/s41598-019-43799-y |
| Popis: | Este es el artículo que se ha publicado de forma definitiva en: https://www.nature.com/articles/s41598-019-43799-y En este artículo también participa J.F. Lisón . The purpose of this study is to investigate whether implementing a myofascial release (MFR) protocol designed to restore the myofascial properties of the diaphragm has any efect on the symptoms, quality of life, and consumption of proton pump inhibitors (PPI) drugs by patients with non-erosive gastroesophageal refux disease (GERD). We randomized 30 patients with GERD into a MFR group or a sham group. Changes in symptomatology and quality of life were measured with the Refux Disease Questionnaire and the Gastrointestinal Quality of Life Index. Need of PPIs was measured as the milligrams of drug intake over the 7 days prior to each assessment. All variables were assessed at baseline, one week and 4 weeks after the end of the treatment. At week 4, patients receiving MFR showed signifcant improvements in symptomatology (mean diference-1.1; 95% CI: −1.7 to −0.5), gastrointestinal quality of life (mean diference 18.1; 95% CI: 4.8 to 31.5), and PPIs use (mean diference-97mg; 95% CI: −162 to −32), compared to the sham group. These preliminary fndings indicate that the application of the MFR protocol we used in this study decreased the symptoms and PPIs usage and increased the quality of life of patients with non-erosive GERD up to four weeks after the end of the treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|